6C06

Mycobacterium tuberculosis RNAP Holo/RbpA/Fidaxomicin

6C06 の概要

• エントリーDOI: 10.2210/pdb6c06/pdb
• 関連するPDBエントリー: 6BZO 6C04 6C05
• EMDBエントリー: 7323
• 分子名称: DNA-directed RNA polymerase subunit alpha, DNA-directed RNA polymerase subunit beta, DNA-directed RNA polymerase subunit beta', ... (9 entities in total)
• 機能のキーワード: initiation, antibiotic, switch region inhibitor, transcription, transcription-antibiotic complex, transcription/antibiotic
• 由来する生物種: Mycobacterium tuberculosis; 詳細
• 細胞内の位置: Cytoplasm : A0A045HD00
• タンパク質・核酸の鎖数: 7
• 化学式量合計: 437917.00

構造登録者

Darst, S.A.,Campbell, E.A.,Boyaci Selcuk, H.,Chen, J.,Lilic, M. (登録日: 2017-12-27, 公開日: 2018-03-28, 最終更新日: 2025-05-14)

主引用文献

Boyaci, H.,Chen, J.,Lilic, M.,Palka, M.,Mooney, R.A.,Landick, R.,Darst, S.A.,Campbell, E.A.
Fidaxomicin jamsMycobacterium tuberculosisRNA polymerase motions needed for initiation via RbpA contacts.
Elife, 7:-, 2018

PubMed Abstract: Fidaxomicin (Fdx) is an antimicrobial RNA polymerase (RNAP) inhibitor highly effective against RNAP in vitro, but clinical use of Fdx is limited to treating intestinal infections due to poor absorption. To identify the structural determinants of Fdx binding to RNAP, we determined the 3.4 Å cryo-electron microscopy structure of a complete RNAP holoenzyme in complex with Fdx. We find that the actinobacteria general transcription factor RbpA contacts fidaxomycin, explaining its strong effect on . Additional structures define conformational states of RNAP between the free apo-holoenzyme and the promoter-engaged open complex ready for transcription. The results establish that Fdx acts like a doorstop to jam the enzyme in an open state, preventing the motions necessary to secure promoter DNA in the active site. Our results provide a structural platform to guide development of anti-tuberculosis antimicrobials based on the Fdx binding pocket.

PubMed: 29480804
DOI: 10.7554/eLife.34823

実験手法

ELECTRON MICROSCOPY (5.15 Å)